What Longevity Researchers Actually Take: The 15-Protocol Blueprint (2026)
Over 90% of longevity content published in 2026 cites the same 30 papers. Nearly 100% of the actionable protocols reduce to 15 interventions.
This is the actual playlist — the ones with RCT evidence, cohort validation, or mechanism-clear rationale — from what the research community publishes, presents at conferences, and takes themselves.
Why "what researchers take" is a better question than "what should I take"
Most longevity content follows a template: reverse-chronological pop-sci summaries. New study drops, headline goes up, three months later a new supplement launches to catch the trend.
The researchers themselves operate differently. They watch the evidence base for a decade. They wait for meta-analyses. They cross-reference cohort data with mechanism plausibility. And then they build a stack — usually short, usually cheap, usually boring — that maps to the intervention categories where the human evidence is strongest.
The list below is drawn from what appears repeatedly in the published stacks of longevity researchers who present at ARDD, IHMC, AACR, and adjacent conferences, cross-referenced against what shows up in the largest observational cohorts (Blue Zones, PREDIMED, MIND, US Nurses Health Study, UK Biobank).
Not brand recommendations. Not sponsored picks. The 15 categories that show up over and over.
The 15-protocol blueprint
1. NAD+ precursor (NMN or NR)
Threshold dose matters more than brand. Human RCTs show measurable NAD+ elevation at 500-900mg NMN or 500-1000mg NR. Below that: methodological noise. Above 1g: minimal additional signal. Split doses have no evidence advantage over single doses.
2. VO2 max training (Zone 2 + Zone 5)
The single strongest all-cause mortality predictor in the epidemiological literature — stronger than smoking, cholesterol, or BMI status. Zone 2 for the mitochondrial biogenesis floor (2-4 hrs/wk); Zone 5 for the peak (2 x 4-min intervals weekly).
3. Resistance training
Muscle mass predicts late-life independence more reliably than any biomarker. Two full-body sessions per week hitting compound movements (squat, hinge, push, pull, carry) covers the volume floor. Progressive overload matters more than periodization sophistication.
4. Sleep architecture (7-hour minimum window)
The 7-hour window, not 7 hours of measured sleep. Deep sleep declines 60% between age 20 and 70; slow-wave amplitude drops linearly. Fixed wake time, morning light, magnesium threonate for slow-wave enhancement in the sub-50 crowd.
5. Mediterranean or MIND diet
The dietary pattern with the deepest cohort data. PREDIMED cut cardiovascular events by 30% in a 5-year RCT. MIND's cognitive decline reduction is smaller but real. Both share the same core: fish, olive oil, nuts, legumes, low ultra-processed intake.
6. Hormesis stack (sauna + cold exposure)
Kuopio Ischemic Heart Disease study: 4-7 sauna sessions per week correlated with 40% lower all-cause mortality over 20 years. Cold exposure's evidence base is smaller but mechanistically converging on BAT activation + norepinephrine reset.
7. Omega-3 (EPA + DHA)
Omega-3 Index above 8% correlates with a 5-year lifespan advantage. Most adults sit at 3-4%. 1,400mg EPA + 480mg DHA daily gets most people into the therapeutic band within 8-12 weeks. Test — do not guess.
8. Vitamin D (with K2)
25-hydroxyvitamin D target of 40-60 ng/mL is where the mortality curve flattens. Dose to hit the target, not the RDA. K2 (MK-7 form) matters if you take D3, because calcium trafficking is dose-dependent on both.
9. Magnesium (bisglycinate or L-threonate)
Magnesium deficiency shows up in half of standard American adults. Bisglycinate for the general RDA gap; L-threonate for cognitive-longevity signal (crosses blood-brain barrier better). Threshold is 200-400mg elemental daily.
10. Methylation cofactors (methyl-B12 + methyl-folate)
MTHFR polymorphism affects 40% of the population. Methylated forms bypass the common defect. Homocysteine above 10 μmol/L is the biomarker to watch — VITACOG showed B-vitamin supplementation reduced brain atrophy by 30% in people with elevated homocysteine.
11. Continuous glucose visibility
Post-meal glucose response is one of the more actionable metabolic markers available to non-clinical adults. Two weeks with a continuous glucose biosensor teaches most people more about food than five years of nutrition apps. The point isn't the sensor — the point is what the data teaches about individual response.
12. Advanced biomarker panel (annual)
The standard physical measures 8 markers. The advanced panel measures 40+, including apoB, Lp(a), hs-CRP, homocysteine, HbA1c, fasting insulin, Omega-3 Index, and 25-hydroxyvitamin D. This is the single most information-dense annual investment in the longevity toolkit.
13. Autophagy signaling (fasting or spermidine)
Intermittent fasting (16:8) has the deepest human evidence; longer fasts have thin RCT data. Spermidine (1-6mg from wheat germ extract) is the compound-based alternative — Bruneck study cohort showed 5-year lifespan advantage in the top spermidine intake tercile.
14. Gut microbiome maintenance
Bacterial diversity correlates with healthspan across every cohort where it has been measured. The mechanisms overlap: SCFA production, LPS translocation, bile acid metabolism, neurotransmitter precursors. Fiber diversity (30+ plant species per week) is the single strongest predictor most under Rob's control.
15. Cognitive-longevity behaviors
Social connection, purpose, and cognitive novelty predict late-life brain function better than any supplement. Loneliness carries a mortality risk equivalent to smoking 15 cigarettes per day. Weekly novelty (new skill, new place, new conversation partner) drives BDNF the way exercise does.
What's NOT on the list
The absences are as informative as the inclusions:
- Rapamycin — Interesting mechanism, thin human evidence at longevity doses. Not on most researcher lists yet.
- Metformin — TAME trial results pending. Most researchers are waiting.
- NAD+ IV infusion — Cost-benefit doesn't hold up vs oral NMN in humans.
- Peptides (BPC-157, thymosin, etc.) — Legal ambiguity plus thin RCT data means researchers stay quiet publicly even if they use them privately.
- Multivitamins — Twenty-seven years of RCTs show no lifespan benefit. The evidence.
- Hormone replacement (beyond deficiency) — Highly individual; researchers are careful with public recommendations.
How the 15 stack together
The blueprint isn't 15 things to do in isolation. It's a system where interventions compound:
- Sleep gates recovery, which gates training volume, which gates VO2 max, which gates cardiovascular mortality.
- Diet gates gut diversity, which gates inflammation, which gates most chronic disease risk.
- Biomarker testing gates dose personalization for D3, omegas, magnesium, and B-vitamins — turning generic advice into targeted intervention.
The compounding is why researchers describe their protocols as stacks, not lists. Each intervention contributes 5-15% to lifespan or healthspan on paper; the combination is nonlinear.
The reference library
Every protocol above has a dedicated research brief in the Purelongevity library — dose thresholds, mechanism summary, RCT citations, and the specific brand-selection criteria that separate a working product from a marketed one. Purchasing each individual guide runs $373. The full bundled library is $97.
15 research-grade protocols. One Vault. $97.
Every protocol above is anchored to peer-reviewed cohort studies. NAD+, VO2 max, sleep, biomarkers, Mediterranean, hormesis, and 9 more — the same research the longevity community actually runs.
⚡ Instant download · delivered to your inbox in 5 minutes · 🛡️ 30-day money-back guarantee
